found in 4.4% of hospital admissions and 6% of general practitioner consultations.
Introduction
In general practice, the most common lower respiratory tract infections (LRTIs) were bronchitis and pneumonia, which were associated with major mortality and morbidity worldwide. [1] On the basis of statistics, it was found that LRTIs were issues of due scientific concern, especially infections caused by Pseudomonas species and P. aeruginosa, in particular. The objective of this study was to determine the prevalence of P. aeruginosa in LRTI patients, inpatients, and outpatients, who attended a tertiary-care hospital in Lucknow, India, and to compare their antibiotic susceptibility pattern.
Materials and Methods
This cross-sectional study was carried out in the Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India, from September 2010 to August 2013. All patients admitted to the Pulmonary Medicine Ward and outpatient department (OPD) were included in this study. All the LRTI patients aged ≥ 18 years with symptoms suggestive of LRTI (i.e., two or more of the following symptoms: cough, sputum production, shortness of breath, wheeze, fever during this illness, and chest pain) who gave written consent were enrolled for the study.
The study was approved by the Institutional Ethics Committee. Sputum samples were collected from LRTI patients. In cases where patients did not produce sputum, bronchoalveolar lavage (BAL) was taken after bronchoscopy, which was done by the concerned physician.
Any patient who presented with fever, cough, expectoration, and/or dyspnea and suspected to have a LRTI as the main diagnosis, including pneumonia, exacerbation of asthma, chronic obstructive pulmonary disease (COPD), and bronchitis was included. All the samples collected (sputum and BAL) were cultured on nutrient agar, blood agar, and Pseudomonas isolation agar and incubated at 37°C overnight. The colonies were identified using various biochemical tests. [5] The antibiotic sensitivity test was performed using "KirbyBauer disc diffusion method." The following antibiotics were tested:; gentamycin (10 μg), amikacin (30 μg), tobramycin (30 μg), ciprofloxacin (5 μg), levofloxacin (5 μg), aztreonam (30 μg), ceftazidime (30 mcg), ceftriaxone (30 μg), ampicillin (100 μg), cefepime (30 μg), piperacillin/tazobactam (100/10 μg), amoxicillin/clavulanic acid (30 μg), imipenem (10 μg), and meropenem (10 μg). Zones of inhibition were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. [6] Multidrug-resistant P.aeruginosa (MDRPA) is defined as non susceptibility to at least one agent in three or more antipseudomonal categories, i.e., aminoglycosides, carbapenems, cephalosporins, fluoroquinolones, and penicillin/β-lactamase antibiotics.
Statistical Methods
The data were analyzed for mean, median, and standard deviation and P value (c 2 with Yates' correction and Fisher's exact test) by using SPSS software, version 16. Statistical significance was defined when P < 0.05.
Result
Among the 270 respiratory samples, 202 (74.8%) of them yielded significant growth, and the rest [68 (25.1%)] of the samples were either sterile or showed contamination. A single pathogen was confirmed in 194 (72.0%) patients and eight (3.0%) revealed mixed bacterial etiology. The most common single pathogen that was isolated was P. aeruginosa (29.6%), followed by Morexilla catarrhalis (11.9%), and Streptococcus pneumoniae (10.3%) [Table1]. The mean age of patients infected with P. aeruginosa was 51.3 or 55 years, standard deviation ± 14.8 years (minimum 18 and maximum 85 years). The gender (male:female) ratio was 4:1, which was not significantly associated (P = 0.093). P. aeruginosa infection was significantly observed among inpatients, elderly (>59 years), associated with and had undergone any invasive procedure (P < 0.002) [ Table 2 ].
The antibiotic resistance pattern is presented in Table 3 . The most effective antibiotic was from carbapenem (i.e., imipenem), and its resistance rate was detected as 10%. Of the 80 samples, 52 were found to be MDRPA.There were several risk factors observed in association with the patients harboring P. aeruginosa including hospital stay, duration of stay, invasive device, comorbidity, and ICU stay. Significant correlation (P = 0.031) was observed between bacterial infections and patients with a hospital stay of more than 72 h at the time of sending the sample.
Male subjects (80%) were generally affected, and the maximum number of cases was seen among the age group 59-85 years [ Table 4 ].
The prevalence of P. aeruginosa in patients with LRTI is shown in Table 5 . COPD patients showed a significant association with P. aeruginosa (P = 0.043), followed by asthma (P = 0.028) and bronchogenic carcinoma (P = 0.044), which showed a significant association with P. aeruginosa.
Discussion
The predominance of P. aeruginosa resistance is considered as serious problem in many countries. It was also reported that P. aeruginosa is one of the most common nosocomial pathogen and a leading cause of nosocomial respiratory tract infection. [4] This study has demonstrated that the major single pathogens causing LRTI are P. aeruginosa (39.6%), M. catarrhalis (11.9%), S pneumoniae (10.3%), and H. influenzae (8.91%). These observations are different from the findings of Ozyilmaz et al. [7] from Turkey and Liebowitz et al. [8] from South Africa, where H. influenzae was the most prevalent single pathogen, followed by S. pneumoniae and M. catarrhalis. The most frequent mixed infection in this study was by Klebsiella species and Pseudomonas species (1.48%), whereas in another study by de Roux et al., [9] S. pneumoniae and H. influenzae constituted the most frequent cause of mixed infection. Occurrence of mixed bacterial infection in this study was 3.96%, and this is consistent with the fact that the incidence of mixed infections does not usually exceed 30%, as has been observed in other series. This study found P. aeruginosa as the most common gram-negative bacteria in LRTIs, as found by a study in North America, [10] but different from another report from Japan. [11] In India, the prevalence rate of P. aeruginosa infection varies from 10.5% to 30%. It ranged from 3% to 16%, in a multicenter study conducted by Lingand Cheng. [12] The prevalence in our study was found to be 39.6%, which is comparable with the above-mentioned study. P. aeruginosa were predominantly isolated from sputum (17.4%), followed by lavage sample (12.2%). Our findings differed from those of Chaudhari et al. [13] (35.3%) who reported that wound infection and respiratory tract infections were found to be commonly affected by P.aeruginosa.
Male preponderance (80%) was noted in this study. Different observations were made by Anupurba et al. (60%) [14] and Idris et al. (57%). [15] Outdoor activity, personal habits, nature of work, and exposure to soil, water, and other areas, which are inhabited by organism, could be the reason for male preponderance. More number of cases [106 (39.2%) cases] were seen between 59 years and 85 years, which is comparable with the studies of Anupurba et al., [14] in which the common age group was between 21 years and 40 years. P. aeruginosa is inherently resistant to many antimicrobial agents, thus posing a great challenge in community-acquired and nosocomial infections. In addition, it has the ability to acquire resistance to many drug classes.
Imipenem, amikacin, and piperacillin/tazobactam were the most effective drugs observed in this study, which showed resistant rates of 10%, 11.2%, and 22.5%, respectively. Low resistance rate of P. aeruginosa to carbapenems and piperacillin/tazobactam may be owing to its recent introduction for use in our hospital.
Among the drugs, levoflxacin (78.2%), ceftriaxone (67.5%), and ceftazidime (62.5%) showed the highest resistance in this study. Yüce et al. (84%) [16] and Aibinu et al. (79.4%) [17] reported more resistance against ceftazidime in their studies. Our study is in line with the reports of Mayank et al. (63%) . [18] Ciprofloxacin showed 42.5% resistance to P. aeruginosa in our study. In various reports on ciprofloxacin resistance to P. aeruginosa, it ranged between 0% and 89%. [19] MDR is pervasive and growing clinical problem, which is recognized as a threat to public health in causing significance effect on morbidity and mortality and increased economic burden, which stems from the misuse of antibiotics, particularly, excessive use.
The percentage of MDR P. aeruginosa in India ranges from 11.36% reported by Idris et al. [15] to 91.6% reported by Paranjothi and Dheepa. [20] In our study, 65% P. aeruginosa were found to be MDR, which is comparable with abovementioned studies.
Our study had certain limitations and strengths such as cross-sectional environment of the study with limited number of patients and period of study but we hope that it clears the way for further research. A limitation of this study could be considered that data were not available about prior antibiotic consumption of patients that might have an effect on likelihood of respiratory flora and sputum culture.
Our study has important implications. The antibiotic profile has been considered an important determinant of LRTI. This call for stringent preventive measures that includes strict infection control practices and judicious use of antibiotics implementation of antibiotic policy.
Conclusion
We can conclude that, for an effective management of LRTIs, awareness on the prevalence and antimicrobial susceptibility pattern of resistant isolates in different geographical settings would provide helpful information to the general practitioner in treatment part, which in turn has a great impact in preventing the mortality and morbidity related with Pseudomonas infections.
